Predictive Oncology Inc.
Market Cap
$1.15M
P/E Ratio
-0.01
EPS
$-141.32
Dividend Yield
0.00%
52-Week Range
$1.54 — $45.90
Volume
14.55K
Avg Volume
141.65K
Beta
1.35
P/E (TTM)
-0.01
Forward P/E
1.32
PEG Ratio
0.00
P/S (TTM)
8.53
P/B (TTM)
-0.02
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
4.25%
ROA (TTM)
-26.88%
ROIC
—
Gross Margin
0.50%
Operating Margin
-14.21%
Net Margin
—
Debt/Equity
-0.02
Current Ratio
0.01
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.29%
EPS Growth (5Y)
+0.48%
Sales Growth (3Y)
+0.05%
Sales Growth (5Y)
+0.03%
EPS Est (This Year)
$1.20
EPS Est (Next Year)
$4.05
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.25
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
726.08K
Float
720.10K
Free Float %
99.18%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
NASDAQ
IPO Date
2010-05-03
Employees
23
CEO
Raymond F. Vennare
Index Membership
—
Website
https://www.predictive-oncology.com
Predictive Oncology Inc. (POAI) is a healthcare company in the medical - instruments & supplies industry listed on the NASDAQ. With a market capitalization of $1.15M, a P/E ratio of -0.01, POAI is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare POAI against other stocks using dozens of fundamental and technical filters.
MHUA
Meihua International Medical Technologies Co., Ltd.
$8.65
+0.23%
$2.74M
GCTK
GlucoTrack, Inc.
$1.13
+0.03%
$641.23K
CNSL.L
Cambridge Nutritional Sciences plc
$1.90
+0.00%
$4.52M
LUCY
Innovative Eyewear, Inc.
$1.13
+0.89%
$5.17M
APS.TO
Aptose Biosciences Inc.
$2.22
+1.37%
$5.67M
IBO.V
Universal Ibogaine Inc.
$0.01
-50.00%
$1.56M
Predictive Oncology Inc. (POAI) has a trailing twelve-month (TTM) P/E ratio of -0.01. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Predictive Oncology Inc. (POAI) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Predictive Oncology Inc. (POAI) has a market capitalization of $1.15 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.